小児感染免疫第20巻第3号

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.

semen quality or those without WBC in semen. In the patients with azoospermia and normal FSH levels (normogonadotropic azzospermia), the antibody (IgG

CLINICAL STUDIES OF UROGENITAL INFECTIONS WITH CHLAMYDIA TRACHOMA TIS Report 2. The Epidemiology of Chlamydial Infections in Okayama District in Japan and Detection of Antibodies to Chlamydiae in the Sera

スライド 1

資料 3 不活化ポリオワクチンの円滑な導入に関する検討会第 3 回会議 ポリオワクチン互換性についての諸外国におけるデータ 2012 年 4 月 23 日 ( 月 ) 中野貴司 ( 川崎医科大学小児科 ) ワクチンの互換性 Interchangeability of vaccines 同一疾患を予防するワクチン製剤の種類が増え また多価混合ワクチンが普及すると 対象者が過去に接種したものと同じ製剤が入手できなかったり

1) Garner J. S.: The Hospital Infection Control Practices Advisory Committee, CDC, Guidelines for Isolation Precautions in Hospitals, 1996. http://wonder.cdc.gov/wonder/prevguid/ p0000419/p0000419.asp.

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection Table 1. Bacterial cell counts in feces of mice infected with Esclwrichia coli O 157: H7 NK2 before and during oral dosing with fosfomycin

/‚“1/ŒxŒ{‚×›î’æ’¶

60 1 pp.3-8 2010 1. H1N1 1) 2) 3) 4) ERATO 2009 H1N1 21 H1N1 HA PB2 2009 3 Pandemic H1N1 2009 WHO 6 11 21 2009 11 2010 4 21 H1N1 H1N1 2009 4 15 CDC 108-8639 4-6-1 TEL: 03-5449-5281 FAX: 03-5449-5408 E-mail:

Table 1 Survival rates of infected mice given antibiotic doses producing peak serum a) S. aurcus Smith Challenge dose :7 ~10 (5% mucin) CFU/mouse. LD50: 1 ~103 (5% mucin) CFU/mouse. Table 2 Survival rates

Fig.1 MICs of penicillins against 24 strains of B. pertussis Fig.2 MICs of cepherns against 24 strains of B. pertussis Fig.3 MICs of macrolides against 24 strains of B. pertussis Fig.4 MICs of nalidixic

Characterization of Anti-HBs Antigen Monoclonal Antibodies and Application to the Subtyping Yoshiya YOSHIDA, Yumiko FURUYA, Masayasu INOUE, Akiyoshi MATSUSHIMA and Kazumasa ODA Kanagawa Prefectural Public

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5

IU/mL.1 IU/mL A , % % 6.% 7 B %.1 IU/mL IU/mL % %.1 IU/mL % 7/9 4

7 1,315 213 KPA.1 IU/mL 21 9% 22 44 75%.1 IU/mL 1975 DPT 45 49 39.7% 5 22.1% Clostridium tetani 1 21 213 4 16 118 118 128 1948 1952 1959 1964 DPT 1968 1975 2 1 4 DPT 1981 DTaP212 DPT-IPV 7 7 1,315 1 2

VOL.32 S-9 CHEMOTHERAPY Table 1 Minimum inhibitory concentrations of AC-1370, CPZ and CAZ Table 2 Efficacy of AC-1370 and CPZ against systemic infections in mice *Inoculum size: 106 cells/ml * 95% confidence

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood Fig.1 Distribution of the cases with bacterial meningitis by age and pathogens Chiba

VERO IU/mL.1 IU/mL A , % % 6.% 7 B %.1 IU/mL IU/mL %.1 IU/mL 1

7 1,348 213 VERO.1 IU/mL 1 82.8% 1 5 9%.1 IU/mL 1 6 9 58.7% 1 46.2% 12 15 8%.1 IU/mL 2 3-34 7% 36.9%1975 DPT 4 54 5% 55 1958 12.9%.1 IU/mL Corynebacterium diphtheriae 1999 1948 1958 DP 1964 DPT 1968 1975

CHEMOTHERAPY Fig. 1 Chemical structure of TE-031

CHEMOTHERAPY Fig. 1 Chemical structure of TE-031 CHEMOTHERAPY Table 1 Experimental groups for active systemic anaphylaxis in guinea pigs : Single dosage Fig. 2 Schedule for active systemic anaphylaxis

untitled

Quantitative Risk Assessment on the Public Health Impact of Pathogenic Vibrio parahaemolyticus in Raw Oyster 1 15 5 23 48 2 21 1 16 1 16 1 11 3 1 3 4 23 1 2 16 12 16 5 6 Hazard IdentificationExposure

..8../8-9 ....

1 2 1933 GNP 3 1962 p OHASHI Toshihiro Abstracts AStudy on the Development of the Cultural Properties Policy in Korea from 1902 until 1962 OHASHI Toshihiro The investigation of cultural properties

小児感染免疫第23巻第1号

Vol. 23No. 163 42 HPV HPV 1113 HPV 42 HPV HPV HPV 1 1 510 1020 HPV 1020 510 HIV 0.1 0.005 HIV 2030 HIV 0.2 510 HPV 1020 15 HIV 2030 HIV HIV 0.2 0.1 Takeyuki Sato 2608677 181 64 2011 2 1 1518 6,000 513

MM0506-Ariyoshi.ind

51 2005133 Six years of experiences at the U.K. MRC Laboratories, The Gambia, in West Africa Koya ARIYOSHI 130 1965 1992 Jonathan Weber Medical Research Council MRC Laboratories, The Gambia HIV Virologist/Immunologist

2

研究成果報告書

Arterioscler Thromb Vasc Biol., 27, 2400 2406 (2007) J. Agri. Food Chem., 59, 4544 4552 (2011) Bioorg. Med. Chem. Lett., 21, 1786 1791 (2011) Advanced glycation end products (AGEs) AGEs AGEs AGEs HbA1c

20 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /0, No. +,,* -* (,**3) 20 * * Taste of Mentsuyu (a Japanese noodle soup) Depends on the Combination and P

20 Nippon Shokuhin Kagaku Kogaku Kaishi Vol. /0, No. +,,* -* (,**3) 20 * * Taste of Mentsuyu (a Japanese noodle soup) Depends on the Combination and Proportion of Ingredients Akiko Otomi Keywords : taste,

Key words: ELISA method, streptococcal antibody, Anti-M protein antibody, whole cell antigen Table 2 Uptake of protein A using different anti-group sera of streptococci Figure shows optical density at

1) i) Barber, M. et al.: Brit. Med J, 2, 565, 19'49. ii) Barber, M.F.G. J. Hayhoe and J. E. M. Whithead: Lancet, 1120 `1125, 1949.-2) Bergey: Bergey's Manual of Determinative Bacteriology 7 th Ed: (1958).-3)

A, B 2 B 5 A C A ADP A G ADP ADP G camp B GM A B CTB Tochikubo et al., 1998 CTB CTB Dertzbaugh & Elson, 1993a; Yu et al., 1994; Shi et al., 1995 CTB C

2004 Analysis of the expression of cholera toxin B-subunit gene 1065010 2004 8 26 1 A, B 2 B 5 A C A ADP A G ADP ADP G camp B GM A B CTB Tochikubo et al., 1998 CTB CTB Dertzbaugh & Elson, 1993a; Yu et

-51-

-50- -51- 11 3 28 8 1 24 7 2 36 10 1-52- -53- 1 2-54- 6 1 2 3 4 5 6 6 1 19 5 200 300ml 20 6 400ml -55- -56- 10-57- 4 2 20-58- 2,500-59- -60- -61- 2-62- 6 3-63- 9 68 1 6-64- 3-65- 4-66- 5 6-67- -68- 1 1

CHEMOTHERAPY APR Fig. 1 Chemical structure of cefotetan (CTT, YM09330)

CHEMOTHERAPY APR. 1982 Fig. 1 Chemical structure of cefotetan (CTT, YM09330) VOL.30 S-1 CHEMOTHERAPY Fig. 2 Comparison of standard curves of CTT on various test organisms by cylinder plate method Column

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

D 012 Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents DATA : 1 DATA : 2 3 DATA : UNGITEC 1 1 DATA : 20pg/mL 1020pg/mL 10pg/mL (cut off 20pg/mL) 90.2%(37/41) 100%(85/85) 96.8%(122/126)

CHEMOTHERAPY AUG. 1982 VOL. 30 NO. 8 CHEMOTHERAPY Fig.1 Relation between various-closis of cefazolin and detection rate of organisms in heart blood of dying mice with E. coli and P. aeruginosa infection

Fig. 2 Signal plane divided into cell of DWT Fig. 1 Schematic diagram for the monitoring system

Study of Health Monitoring of Vehicle Structure by Using Feature Extraction based on Discrete Wavelet Transform Akihisa TABATA *4, Yoshio AOKI, Kazutaka ANDO and Masataka KATO Department of Precision Machinery

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration

1272 CHEMOTHERAPY MAR. 1975

1272 CHEMOTHERAPY MAR. 1975 VOL. 23 NO. 3 CHEMOTHERAPY 1273 Fig. 2 Minimal inhibitory concentration of aminoglycosides against 50 strains of Klebsiella Fig. 1 Minimal inhibitory concentration of aminoglycosides

Key wards: cyclophosphamide, neutropenic mice, Pseudomonas aeruginosa, experimental pyelonephritis, G-CSF

Key wards: cyclophosphamide, neutropenic mice, Pseudomonas aeruginosa, experimental pyelonephritis, G-CSF Pseudomonas aeruginosa Fig. 1 Method of administration of cyclophosphamide and G-CSF CPM group

Introduction ur company has just started service to cut out sugar chains from protein and supply them to users by utilizing the handling technology of

Standard PA-Sugar Chain Catalogue Masuda Chemical Industries Co., LTD. http://www.mc-ind.co.jp Introduction ur company has just started service to cut out sugar chains from protein and supply them to users

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo

Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly

untitled

---------- - 1 - ----- 1 Q1 5 Q2 5 Q3 5 Q4 6 Q5 6 Q6 7 Q7 7 Q8 7 Q9 8 Q10 : 8 10 Q1 10 Q2 11 Q3 11 12 Q4 12 Q5 HBs HBc _12 Q6 HBe 12 Q7 13 Q8 NAT 15 Q9 15 Q10 15 Q11 HBs 16 Q12 HBV DNA 16 Q13 17-2 - Q14

CHEMOTHERAPY

CHEMOTHERAPY VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin CHEMOTHERAPY AUG. 1993 VOL.41 S-2 Laboratory and clinical evaluation of teicoplanin Table 1. Comparative in vitro activity of teicoplanin

スライド 1

Post-Polio Syndrome; PPS 2008 2 23 PoliomyelitisPolio PPS 18 BC1580 BC1350 30nm Iron Lung 1930 1916 27,363 7,179 26.2% Rancho Los Amigos National Rehabilitation Center Incidence Rates of Poliomyelitis

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

VOL.39 S-1 CHEMOTHERAPY FEB. 1981 Table 1. Activity of cefpirome and others against clinical isolates VOL.39 S-1 CHEMOTHERAPY FEB. 1991 72 M, 55.5 kg 66 F, 53 kg Chronic bronchitis Bronchopneumonia Peak

Fig. 1. Structures of NM394, NAD-358 and NAD-245 Fig. 2. Typical HPLC chromatograms of NM394 in human plasma by organic solvent extraction method (a): Blank plasma (b): Plasma spiked with NM394 and internal

988 CHEMOTHERAPY NOV. 1971

988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical

CHEMOTHERAPY JUN Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter cloacae 27, Proteus rettgeri 7, Proteus inconstans 20, Proteus

VOL. 32 S-4 CHEMOTHERAPY Fig. 1 Chemical structure of sodium cefoperazone Fig. 2 Chemical structure of sodium cefoperazone CHEMOTHERAPY JUN. 1984 Citrobacter freundii 27, Enterobacter aerogenes 26, Enterobacter

Effect of Cooking Water ph on Commercial Sterility in the Production of Cooked Rice Packed under Semi-aseptic Condition Kinya SAKUMAl, Haruhiko KATODA1, Tetsuya FUKAYA2, Toshio JOH3, Akira IT03 and Atsuo

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Ent

Fig.2. Sensitivity distribution of clinical isolates of S. epidermidis (24 strains, 106 CFU/ml) Staphylococcus aureus Staphylococcus epider- midis Enterococcus faecalis Klebsiella pneumoniae, Morganella

Optical Lenses CCD Camera Laser Sheet Wind Turbine with med Diffuser Pitot Tube PC Fig.1 Experimental facility. Transparent Diffuser Double Pulsed Nd:

*1 *2 *3 PIV Measurement of Field of the Wind Turbine with a med Diffuser Kazuhiko TOSHIMITSU *4, Koutarou NISHIKAWA and Yuji OHYA *4 Department of Mechanical Engineering, Matsue National Collage of Technology,

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 2-1. Summary of patients treated with grepafloxacin for respiratory infection 1) Out: outpatient,

/

333 344 / 332 03-6264-066003-6264-0663 03-6264-0620 334 LAL 335 336 LAL 338 QCL-1000 LAL 33 LAL 340 C 341 LAL 343 ELx808 344 FLx800 345 PyroTec 346 WinKQCL 347 CSE 348 / 03-6264-066003-6264-0663 03-6264-0620

1_alignment.ppt

" " " " n " n n " n " n n n " n n n n " n LGPSSKQTGKGW-SRIWDN! + +! LN-ITKSAGKGAIMRLGDA! " n -------TGKG--------!! -------AGKG--------! " n w w w " n w w " " " 11 12 " n w w w " n w w A! M! O! A!

<95AA8E718CA4838C835E815B D862E696E6464>

T1r T1r1 T1r3 T1r2 T1r3 [1] T1r T1r 500 LBD 1 LBD T1rLBD [2] T1r T1r2a T1r3 LBD [3] T1r2a/T1r3 L- [4] T1r2a/T1r3LBD M~ M T1rLBD FRET FRET T1rLBD [3] 1 T1r 2 T1r2a/T1r3 X [3] 28 75 March 2017 T1rLBD imsaxst1r2a/t1r3lbd

ICT n n n A A A A A A A A A ICT The 2nd East Asia International Conference on Teacher Education Research http : //www/mext.go.jp/a_menu/koutou/kyoushoku/kyoushoku. htm Comparison of Japanese-Chinese Education

2 (1) (2) SCI 2 SCI 2 24 2 12 2

2004 (1) (2) (2) (3) (1) 1 (2) (3) 2 (1) (2) SCI 2 SCI 2 24 2 12 2 100% / 16 2002 2003 http://lin.lin.go.jp/alic/month/dome/1997/nov/chousa.htm (05 612 1315 1618 1922 2329 3039 4049 5059 60 ) =10 b g 1

Key words : R-plasmid, Urinary tract infection, E. coli Fig. 1. MIC distribution against E. coli isolated from urinary tract (366 strains) and isolation - frequencies of drug-resistant strains Table 1.

_学生通信Vol16.indd

X X 1. 1 X 2 X 195 3, 4 Ungár modified Williamson-Hall/Warren-Averbach 5-7 modified modified Rietveld Convolutional Multiple Whole Profile CMWP 8 CMWP

X X a a b b c Characterization of dislocation evolution during work hardening of stainless steels by using XRD line-profile analysis Tomoaki KATO a, Shigeo SATO a, Yoichi SAITO b, Hidekazu TODOROKI b and

Fig.1 Chemical structure of BAY o 9867

Fig.1 Chemical structure of BAY o 9867 CHEMOTHERAPY 43 Table 3 Antibacterial spectrum of gram negative bacteria Medium:Heart infusion agar (Nissui) Method:Agar dilution (Streak) CHEMOTHERAPY DEC 1985

Fig. 1 Chemical structure of DL-8280

Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.

住宅（本文、図表）

360 1970 90 1999 121 20 4.1 10 5-1 1990 1993 1.6 1.7 1996 1.55 1990 5-2 1970 98 5-3 41 141 80 1944 1.5 90 90 5-1 90 1991 5-4 150 1.99 5.44 99 2.08 2000 2.66 4.52 3.12 2.26 1.36 283 58 1.54 3.12 1.99 2.08

No21Vol1.indd

( ): - PSA Shojiro Kano Head, Working Group of PSA Testing Standardization Committee (PSA) PSA PSA JCCLS PSA A PSA B PSA PSA Wang PSA FDA Hybritech Tandem-R PSA PSA PSA PSA - (ACT) - (AMG) ACT (PSA-ACT)

蝨ｰ蝓溯・豐ｻ縺ｨ繧ｳ繝溘Η繝九ユ繧｣蠖｢謌舌↓髢｢縺吶ｋ螳滓・隱ｿ譟ｻ・域擲莠ｬ迚茨ｼ峨€仙悸邵ｮ縺ｪ縺励€・indd

1 1 2 3 3 1 3 2 4 5 6 7 8 8 1 8 2 1 2 2014 10 10 2014 10 20 1 2008 7 30 6 30 2020 30 2 2002 IT IT 2000 2005 IT 3 2008 JASSO, 20122012 37,989 7,910 22.2 3 4,684 13.2 4,092 11.5 12,594 35.4 6 2008 9,684

Medical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 10 (2012) Key words ö γ µ Graves disease and Hashimoto s thyroiditis are autoimmune thyroid diseases. Graves disease causes

202

201 Presenteeism 202 203 204 Table 1. Name Elements of Work Productivity Targeted Populations Measurement items of Presenteeism (Number of Items) Reliability Validity α α 205 α ä 206 Table 2. Factors of

19 8 1970 20 10 4 1

19 8 1970 20 10 4 1 IgE 1960 % 1970 20%, 1990 40% 1998 70% 20 IgE 21 90% IgE IgE (%) 70 60 50 40 30 20 10 0 1970 1975 1980 1985 1990 1995 2000 2005 1. 2005 10 2 30 IgE 2. 3 1. B IgE T IgE IgE IgE 2 T IgE

The Heart Healthy Tocotrienol Complex Tocomin SupraBio

The Heart Healthy Tocotrienol Complex Tocomin SupraBio The Heart Healthy Tocotrienol Complex Tocomin SupraBio 1. Fact Sheet No. 317; World Health Organization (WHO), 2007 2. LLOYD-JONES D. et al. Circulation

Table 1 Characteristics of the study participants in Imari municipal hospital

Key words: tuberculosis, booster phenomenon, two-step tuberculin test Table 1 Characteristics of the study participants in Imari municipal hospital Fig. 1 Frequency distributions of size of the first tuberculin

技術研究報告第２６号

1) 2) 3) 250Hz 500Hz RESEARCH ON THE PHYSICAL VOLUME OF THE DYNAMIC VIBRATION RESPONSE AND THE REDUCTION OF THE FLOOR IMPACT SOUND LEVEL IN FLOORS OF RESIDENTIAL HOUSING Hideo WATANABE *1 This study was

Jpn.J.Leprosy 67, (1998)

Jpn.J.Leprosy 67,287-291(1998) Fig.1. Macroscopic appearance of the cultured slides stained by the Ziehl-Neelsen method. Up to bottom: kept at 4 C, 18 weeks, cultured for 6 weeks, 8 weeks, 10 weeks, 12

Core Ethics Vol. Epstein, CI CI CI CI CI CI CI CI Epstein, CI CI CI CI CI CI CI CI CI CI Schindler, CI CI CI CI NIH CI Finn FDA / M CI N CI N / M, CI

Core Ethics Vol. Cochlear Implant CI,, CI CI,,, CI CI CI CI CI, CI CI CI CI CI CI CI CI CI CI CI CI CI Core Ethics Vol. Epstein, CI CI CI CI CI CI CI CI Epstein, CI CI CI CI CI CI CI CI CI CI Schindler,

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Table 1. Clinical summary of acute uncomplicated cystitis patients treated with 7432-S UTI : Criteria by the

,,,,., C Java,,.,,.,., ,,.,, i

24 Development of the programming s learning tool for children be derived from maze 1130353 2013 3 1 ,,,,., C Java,,.,,.,., 1 6 1 2.,,.,, i Abstract Development of the programming s learning tool for children

2017 年 1 月改訂 自動分析用コレステスト N キャリブレーター 本品は下表の試薬のキャリブレーターとして使用するものです 使用法 本品 1バイアルに精製水 2.0mL を正確に加えて溶解してください 溶解を確認後緩やかに 20 回程度 転倒混和し 所定の時間常温で静置しま

2017 年 1 月改訂 770149104 自動分析用コレステスト N キャリブレーター 本品は下表の試薬のキャリブレーターとして使用するものです 使用法 本品 1バイアルに精製水 2.0mL を正確に加えて溶解してください 溶解を確認後緩やかに 20 回程度 転倒混和し 所定の時間常温で静置します なお 使用前には緩やかに転倒混和します 各濃度はロット毎に説明書に記載してあります 調製後の安定性は

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F

VOL.43 S-1 coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, Flavobacter- Table 1. Concentration of grepafloxacin

国土技術政策総合研究所　研究資料

ISSN TECHNICAL NOTE of National Institute for Land and Infrastructure Management No256 September 2005 Experimental Study on Seismic Behavior of Seawalls for Controlled Waste Disposal Shingo KANO, Katsuya

Rinku General Medical Center

Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines

0. 1. Opening Ceremony 2. Table Discussion (A~F) 3. Table Rotation 4. Symposium 5. Curriculum Exchange 6. Legal Course 7. Welcome Party 8. Life Style

Study Trip from Japan to Korea 2008 Over Pride and Prejudice ALSA Korea 18 th ~25 th, August, 2008 Seoul, Korea 0. 1. Opening Ceremony 2. Table Discussion (A~F) 3. Table Rotation 4. Symposium 5. Curriculum

4703ALL01

473201010 *** (1999) 16 2017 20023 2 1 2 1220 (1999a),(1999b) (1998), (2002) (2003)(1999)(2003) Conjoint Analysis Conjoint Analysis Willingness to PayStandard gamble Time trade-off Rating Scale Willingness

J. Soc. Cosmet. Chem. Jpn. 7-chome, Edogawa-ku, Tokyo 132, Japan 2.1 J. Soc. Cosmet. Chem. Japan. Vol. 31, No

J. Soc. Cosmet. Chem. Jpn. 7-chome, Edogawa-ku, Tokyo 132, Japan 2.1 J. Soc. Cosmet. Chem. Japan. Vol. 31, No. 2 1997 167 Fig.-1 Balanced fiber method Fig.-2 The effects of perming and IG on breaking off

VOL.30 NO.12 CHEMOTHERAPY Fig. 1 Effect of temperature on the growth curve of A. calcoaceticus A. calcoaceticits Ac 54 A. calcoacetictts Ac 164 Fig. 2 Effect of medium ph on the growth curve of A. calcoaceticus

第七回道路橋床版シンポジウム論文報告集 Experimental Study on Fatigue Resistance of RC Slab with UFC Panel for Wheel Running Fatique Test * ** ** *** **** Kazuhiko Minaku

第七回道路橋床版シンポジウム論文報告集 Experimental Study on Fatigue Resistance of RC Slab with UFC Panel for Wheel Running Fatique Test ************ Kazuhiko Minakuchi, Tadashi Abe, Tetsukazu Kida, Satoshi Tanaka and Yuuki

Key words: Pertussis HA vaccine, Single radial hemolysis, Fimbrial hemagglutinin

Key words: Pertussis HA vaccine, Single radial hemolysis, Fimbrial hemagglutinin 513 昭 和56年7月20日 4倍 稀 釈 した 被 検 血 清 を マ イ ク ロ ピペ ッ ト に て5μlず つ 加 え る.こ 骨 した 後,補 れ を4 15時 間静 体 と して0.11MPBS(-)で 4倍 稀 釈 した

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

CHEMOTHERAPY CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY Table 1 Preliminaly test of AM- 715 1): Mean } SD *: Significant difference

食糧　その科学と技術　No.45(2007.03)

PCR γ Bacillus subtilis natto Bacillus subtilis Bacillus subtilis Bacillus subtilis 168 γ Insertion sequence γ L D α γ Bacillus Bacillus subtilis Bacillus licheniformis Bacillus anthracis Bacillus megaterium

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書（案）

VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical Co.);

VOL.35 S-2 CHEMOTHERAPY Fig.1 Chemical structure of carumonam CHEMOTHERAPY JUNE 1987 Table1 Media used *BHIB, brain heart infusion broth (Difco); /3 -NAD, S -nicotinamidoadeninedinucleotide (Sigma Chemical

日本組織適合性学会誌第23巻2号

Major Histocompatibility Complex 2016; 23 (2): 115 122 HLA 1 1) 1) HLA MHC 1900 HLA HLA キーワード : HLA HLA HLA HLA 2 HLA HLA HLA 3 1 1 HLA HLA 図 1 2016 6 30 2016 8 2 105 0013 1 10 14 3 5 TEL: 03 5776 0048

０４０１４８９‐工芸‐医用画像２２‐１／１２［論文］柳田

364-8501 6-100 321-3292 20-2 XR 277-0804 2-1 2004 10 3 2004 12 6 Effectiveness of Mobile Flat Panel Detector system Satoshi YANAGITA, Masako HITACHI, Tomoyuki SAKURAI, Yoshihiro SUZAKI, Takashi OGURA Eiji

untitled

7 ( ). 1. 2. 3. 4. 5. 6. . 1. (C.difficile associated disease CDAD) 1) CDAD 60 72 2 CDAD Toxin CDAD 2) (1) C.difficile C.difficile (2) C.difficile (toxin A toxin B) toxin A toxin B (A+B+) toxin A toxin

24回日本エイズ学会誌1_ indd

10 ICAAP 11 24 9:40 10:10 1 B1F 1. 10 Myung-Hwan Cho 2. Zahid Hussein President of AIDS Society of Asia and the Pacific ASAP 11 24 13:10 15:40 1 B1F 1 13:10 13:55 PS1-1 ART in the Developing World: Progress

Key words: Antibodies to Leptospira, Tokyo, Uveitis

Key words: Antibodies to Leptospira, Tokyo, Uveitis Fig. 1 Distribution of Antibody Titers in Age Decade Fig. 3 Distribution of Antibody Titers in each Strain Fig. 2 Correlation between Antibody Titers

258 5) GPS 1 GPS 6) GPS DP 7) 8) 10) GPS GPS 2 3 4 5 2. 2.1 3 1) GPS Global Positioning System

Vol. 52 No. 1 257 268 (Jan. 2011) 1 2, 1 1 measurement. In this paper, a dynamic road map making system is proposed. The proposition system uses probe-cars which has an in-vehicle camera and a GPS receiver.

医療事故の現状と課題－医療事故への対応策の整備を中心に－

1 2 1 2 3 1 2 3 1 I II 1 1 1993 5 442 2002 896 10 1 5 14 http://courtdomino2.courts.go.jp/shanyou.nsf/0258b7a1680aa82849256467004875a6/352546364a541 14049256d5c000dde7f?OpenDocument 22% 2 3 4 5 2 6 1997

366 12 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 1 8 DNA 2,3 16 12 20 171 2008 12 2010 11 2 3,558 4.44% 1.65% 1.17% 90% 9 Escherichia coli -

Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 365 11 sita oxacin 1 1 1 1 1 1 2 2 3 3 1 1 1 2 3 2012 9 14 sita oxacin STFX 50 mg 10% 2008 1 2008 12 2010 11 2 STFX 1,452 91.4% 1,235/1,351 95.9% 466/486

9 2008 September VOL.160

Vol.160 9 2008 September VOL.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160 Vol.160

% ORG/WIKI/FILE:SALKWS.JPG 1. ORG/WIKI

3 3.1 世界的なポリオ根絶 67 3, 7 8 1789 19 19 198 55. 8. HTTP://WWW. POLIOERADICATION.ORG/ POLIOANDPREVENTION. ASPX 1931 19511233 1949 3 55 7. HTTP://UPLOAD.WIKIMEDIA.ORG/WIKIPEDIA/ COMMONS/5/5C/POLIO_EGYPTIAN_STELE.JPG.

Fig. 4. Configuration of fatigue test specimen. Table I. Mechanical property of test materials. Table II. Full scale fatigue test conditions and test

(J. Soc. Mat. Sci., Japan), Vol. 52, No. 11, pp. 1351-1356, Nov. 2003 Fatigue Life Prediction of Coiled Tubing by Takanori KATO*, Miyuki YAMAMOTO*, Isao SAWAGUCHI** and Tetsuo YONEZAWA*** Coiled tubings,

Table 1. Antibacterial activity of cefdinir, cefixime, cefteram, cefuroxime, cefaclor and amoxicillin against standard strains Inoculum size: 108 cells/ml CFDN: cefdinir, CFIX: cefixime, CFTM: cefteram,

1 Q A 82% 89% 88% 82% 88% 82%

Table 1. Reluctance equalization design. Fig. 2. Voltage vector of LSynRM. Fig. 4. Analytical model. Table 2. Specifications of analytical models. Fig

Mover Design and Performance Analysis of Linear Synchronous Reluctance Motor with Multi-flux Barrier Masayuki Sanada, Member, Mitsutoshi Asano, Student Member, Shigeo Morimoto, Member, Yoji Takeda, Member

Key words : influenza, nested-pcr, serotype

Key words : influenza, nested-pcr, serotype Table 1 Sequence of PCR primers used to detect HA gene of influenza virus 524 清水 Fig. 1 Detection of PCR product 英明 他 (lstpcr) Table 2 Results method Fig. 2